Similar articles

• Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.

  De Backer D, Aldecoa C, Njimi H, Vincent JL. De Backer D, et al. Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee. Crit Care Med. 2012. PMID: 22036860
• Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.

  Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE. Vasu TS, et al. J Intensive Care Med. 2012 May-Jun;27(3):172-8. doi: 10.1177/0885066610396312. Epub 2011 Mar 24. J Intensive Care Med. 2012. PMID: 21436167 Review.
• Recommendations for the treatment of patients with septic shock.

  Meier-Hellmann A, Reinhart K. Meier-Hellmann A, et al. Acta Anaesthesiol Scand Suppl. 1997;111:177-80. Acta Anaesthesiol Scand Suppl. 1997. PMID: 9421002 No abstract available.
• Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.

  Schmoelz M, Schelling G, Dunker M, Irlbeck M. Schmoelz M, et al. J Cardiothorac Vasc Anesth. 2006 Apr;20(2):173-8. doi: 10.1053/j.jvca.2005.10.016. Epub 2006 Feb 21. J Cardiothorac Vasc Anesth. 2006. PMID: 16616656 Clinical Trial.
• Dopamine versus norepinephrine for the treatment of septic shock EBEM commentators.

  Sandifer JP, Jones AE. Sandifer JP, et al. Ann Emerg Med. 2012 Sep;60(3):372-3. doi: 10.1016/j.annemergmed.2012.04.012. Epub 2012 May 5. Ann Emerg Med. 2012. PMID: 22560465 Review. No abstract available.